Eton Pharmaceuticals (ETON) Amortization of Deferred Charges (2024 - 2025)
Eton Pharmaceuticals (ETON) reported Amortization of Deferred Charges of $9000.0 for Q4 2025, down 47.06% on a YoY basis from $17000.0 in Q4 2024, and up 80.0% sequentially from $5000.0 in Q3 2025.
Eton Pharmaceuticals (ETON) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 2 years of Amortization of Deferred Charges data on file, last reported at $9000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortization of Deferred Charges fell 47.06% year-over-year to $9000.0; the trailing twelve-month figure through Dec 2025 stood at $44000.0 (down 37.14% YoY), and the FY2025 full-year result was $44000.0, down 37.14% from the prior year.
- Amortization of Deferred Charges rose to $9000.0 in Q4 2025, from $5000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $18000.0 in Q1 2024 to a low of $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.94 Bn | 32.20 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.24 Bn | 18.43 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn |
| 10 | Eton Pharmaceuticals | 1.14 Bn | 1.11 Bn | 13.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |